1044 related articles for article (PubMed ID: 30472417)
1. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis.
Gao Y; Feng J; Yang G; Zhang S; Liu Y; Bu Y; Sun M; Zhao M; Chen F; Zhang W; Ye L; Zhang X
Hepatology; 2017 Nov; 66(5):1413-1429. PubMed ID: 28608964
[TBL] [Abstract][Full Text] [Related]
3. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.
Rivière L; Quioc-Salomon B; Fallot G; Halgand B; Féray C; Buendia MA; Neuveut C
Antiviral Res; 2019 Dec; 172():104618. PubMed ID: 31600532
[TBL] [Abstract][Full Text] [Related]
5. Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients.
Datta S; Roychoudhury S; Ghosh A; Dasgupta D; Ghosh A; Chakraborty BC; Ray S; Gupta S; Santra AK; Datta S; Das K; Dhali GK; Chowdhury A; Banerjee S
PLoS One; 2014; 9(7):e102573. PubMed ID: 25032957
[TBL] [Abstract][Full Text] [Related]
6. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein modulates remodelling of minichromosomes related to hepatitis B virus replication in HepG2 cells.
Luo L; Chen S; Gong Q; Luo N; Lei Y; Guo J; He S
Int J Mol Med; 2013 Jan; 31(1):197-204. PubMed ID: 23128981
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma.
Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
Biochim Biophys Acta; 2016 Apr; 1862(4):837-849. PubMed ID: 26791804
[TBL] [Abstract][Full Text] [Related]
9. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
10. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC.
Jiao F; Long L; Ding S; Xie X; Jia L; Lu F
Microb Pathog; 2017 Aug; 109():49-55. PubMed ID: 28478205
[TBL] [Abstract][Full Text] [Related]
11. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.
Wong DK; Huang FY; Lai CL; Poon RT; Seto WK; Fung J; Hung IF; Yuen MF
Hepatology; 2011 Sep; 54(3):829-36. PubMed ID: 21809355
[TBL] [Abstract][Full Text] [Related]
13. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
[TBL] [Abstract][Full Text] [Related]
14. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma.
Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Tuvin D; Hiotis SP
J Med Virol; 2016 Feb; 88(2):244-51. PubMed ID: 26174662
[TBL] [Abstract][Full Text] [Related]
15. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
Freitas N; Lukash T; Gunewardena S; Chappell B; Slagle BL; Gudima SO
J Virol; 2018 May; 92(10):. PubMed ID: 29491161
[TBL] [Abstract][Full Text] [Related]
16. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
17. Impact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence.
Wang Q; Lin L; Yoo S; Wang W; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu J; Hiotis SP
Br J Cancer; 2016 Sep; 115(7):841-7. PubMed ID: 27537392
[TBL] [Abstract][Full Text] [Related]
18. Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.
Saeed U; Kim J; Piracha ZZ; Kwon H; Jung J; Chwae YJ; Park S; Shin HJ; Kim K
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567987
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
